Home LiteratureArticle Details
PMID: 30285325 Published · ppublish English Letter Comment

Cabozantinib in Hepatocellular Carcinoma.

The New England journal of medicine ·Vol. 379 ·No. 14 ·2018-00-04 ·Pages 1384

Maeda O, Ando Y

Abstract

暂无摘要

MeSH Terms
Anilides Antineoplastic Agents Carcinoma, Hepatocellular Humans Liver Neoplasms Protein Kinase Inhibitors Pyridines
Chemicals
Anilides Antineoplastic Agents Protein Kinase Inhibitors Pyridines cabozantinib
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Maeda Osamu
Nagoya University Hospital, Nagoya, Japan | [email protected]
Ando Yuichi
Nagoya University Hospital, Nagoya, Japan
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
1533-4406
Published
2018-00-04
Pages
1384
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Corrections
CommentOn
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]